Health TrialsbyHealthPanel

MyPEEPS LITE Trial

ConditionHIV/AIDS
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age16-29
SponsorColumbia University

About this trial

This study will use community-informed advertisements and messages through electronic methods to recruit and retain a large (N=3,200), diverse national sample of high-risk young men who have sex with men (YMSM) and non-binary individuals that are assigned male sex at birth, 16-29 years of age to determine the efficacy of the MyPEEPS Mobile intervention on reduced incident HIV infections in comparison to a standard of care condition and to examine the degree to which reduced incident HIV infections occurs in the context of potential multilevel moderators and conceptual mediators. This is key to advancing HIV prevention among HIV-negative US persons at extremely high-risk for HIV seroconversion.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Be between 16-29 years of age;

Sex assigned at birth is male and identify gender as male or non-binary;

Understand and read English;

Live within US and its territories;

Disqualifiers

Individuals who identify as transgender

Trial design

Design model

Parallel

Treatments tested in this trial

  • MyPEEPS Mobile

    Behavioral

    An evidence-based, digitally delivered mHealth sexual risk reduction intervention on HIV incidence.

Treatment groups

3,200 Participants
are divided into 2 treatment groups
Group A: ControlNo intervention 0 interventions
Group B: InterventionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

HIV Incidence

OraQuick In-Home HIV Tests will be shipped to participants at baseline, 6 and 12 months.

Time frame
Baseline, 6 month follow up, 12 month follow up.
2

Total Condomless Anal Sex Occurring in the Context of Insufficient PrEP Protection

Condomless anal sex acts not protected by PrEP, defined as condomless anal sex acts in the prior 6 months without protection via PrEP. We will measure sexual risk with the AIDS-Risk Behavior Assessment.

Time frame
Baseline, 6 month follow up, 12 month follow up.

Secondary outcomes

1

Self-Reported PrEP Initiation

Self reported PrEP initiation variables will be measured for the purposes of characterizing the uptake of PrEP over the course of the study. We will use a self-reported approach to capture the date of initiation of medication, current use, and most recent date the medication was taken.

Time frame
Baseline, 6 month follow up, 12 month follow up.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Columbia University

Lead sponsor

Ann & Robert H Lurie Children's Hospital of Chicago

Collaborator

Northwestern University

Collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborator

Source ClinicalTrials.gov
Apply now